The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Author Title [ Type(Desc)] Year
Journal Article
Giamarellos-Bourboulis, E. J., Tsangaris I., Kanni T., Mouktaroudi M., Pantelidou I., Adamis G., et al. (2011).  Procalcitonin as an early indicator of outcome in sepsis: a prospective observational study.. J Hosp Infect. 77(1), 58-63.
Hatzistilianou, M., Rekliti A., Athanassiadou F., & Catriu D. (2010).  Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia.. Inflamm Res. 59(5), 339-47.
Scarisbrick, J. J., Quaglino P., Prince H. M., Papadavid E., Hodak E., Bagot M., et al. (2019).  The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.. Br J Dermatol. 181(2), 350-357.
Kosmidis, C., Sardeli C., Zarogoulidis P., Hohenforst-Schmidt W., Vagionas A., Ioannis-Katsios N., et al. (2020).  Producing the appropriate model and drug for intratumoural ablation.. Br J Cancer. 123(3), 335-336.
Papadopoulou, L. C., Ingendoh-Tsakmakidis A., Mpoutoureli C. N., Tzikalou L. D., Spyridou E. D., Gavriilidis G. I., et al. (2018).  Production and Transduction of a Human Recombinant β-Globin Chain into Proerythroid K-562 Cells To Replace Missing Endogenous β-Globin.. Mol Pharm. 15(12), 5665-5677.
Brinkmann, A., Andrusch A., Belka A., Wylezich C., Höper D., Pohlmann A., et al. (2019).  Proficiency Testing of Virus Diagnostics Based on Bioinformatics Analysis of Simulated High-Throughput Sequencing Data Sets.. J Clin Microbiol. 57(8), 
Giagtzidis, I. T., Kadoglou N. P., Mantas G., Spathis A., Papazoglou K. O., Karakitsos P., et al. (2017).  The Profile of Circulating Matrix Metalloproteinases in Patients Undergoing Lower Limb Endovascular Interventions for Peripheral Arterial Disease.. Ann Vasc Surg. 43, 188-196.
Polyzos, S. A., Anastasilakis A. D., Litsas I., Efstathiadou Z., Kita M., Arsos G., et al. (2010).  Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease.. J Bone Miner Metab. 28(6), 706-12.
Fotiadu, A., Tzioufa V., Vrettou E., Koufogiannis D., Papadimitriou C. S., & Hytiroglou P. (2004).  Progenitor cell activation in chronic viralhepatitis.. Liver Int. 24(3), 268-74.
Lei, K., Georgiou E. X., Chen L., Yulia A., Sooranna S. R., Brosens J. J., et al. (2015).  Progesterone and the Repression of Myometrial Inflammation: The Roles of MKP-1 and the AP-1 System.. Mol Endocrinol. 29(10), 1454-67.
Venetis, C. A., Kolibianakis E. M., Bosdou J. K., & Tarlatzis B. C. (2013).  Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles.. Hum Reprod Update. 19(5), 433-57.
Griesinger, G., Mannaerts B., Andersen C. Yding, Witjes H., Kolibianakis E. M., & Gordon K. (2013).  Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials.. Fertil Steril. 100(6), 1622-8.e1-3.
Van Vaerenbergh, I., Fatemi H. M., Blockeel C., Van Lommel L., P Veld I't., Schuit F., et al. (2011).  Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression.. Reprod Biomed Online. 22(3), 263-71.
Papanikolaou, E. G., Kolibianakis E. M., Pozzobon C., Tank P., Tournaye H., Bourgain C., et al. (2009).  Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer.. Fertil Steril. 91(3), 949-52.
Koutras, A., Kotoula V., & Fountzilas G. (2015).  Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer.. Pharmacogenomics. 16(1), 79-94.
Pectasides, E., Chatzidakis I., Kotoula V., Koliou G-A., Papadopoulou K., Giannoulatou E., et al. (2020).  Prognostic Biomarkers in Early-stage Gastric Adenocarcinoma Treated With Adjuvant Chemoradiotherapy.. Cancer Genomics Proteomics. 17(3), 277-290.
Psyrri, A., Lee J-W., Pectasides E., Vassilakopoulou M., Kosmidis E. K., Burtness B. A., et al. (2014).  Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303.. Clin Cancer Res. 20(11), 3023-32.
Kakaletsis, N., Moralidis E., Iliadis F., Hilidis I., Gotzamani-Psarrakou A., & Didangelos T. (2013).  The prognostic efficacy of myocardial perfusion imaging in optimally treated diabetic patients with no manifestations of coronary artery disease.. Nucl Med Commun. 34(9), 885-92.
Levva, S., Kotoula V., Kostopoulos I., Manousou K., Papadimitriou C., Papadopoulou K., et al. (2017).  Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.. Cancer Genomics Proteomics. 14(3), 181-195.
Tsitsopoulos, P. P., Tobieson L., Enblad P., & Marklund N. (2012).  Prognostic factors and long-term outcome following surgical treatment of 76 patients with spontaneous cerebellar haematoma.. Acta Neurochir (Wien). 154(7), 1189-95.
Moumtzi, D., Lampaki S., Zarogoulidis P., Porpodis K., Lagoudi K., Hohenforst-Schmidt W., et al. (2016).  Prognostic factors for long term survival in patients with advanced non-small cell lung cancer.. Ann Transl Med. 4(9), 161.
Petratos, D. V., Kokkinakis M., Ballas E. G., & Anastasopoulos J. N. (2013).  Prognostic factors for premature growth plate arrest as a complication of the surgical treatment of fractures of the medial malleolus in children.. Bone Joint J. 95-B(3), 419-23.
Economopoulou, P., Kotoula V., Koliou G-A., Papadopoulou K., Christodoulou C., Pentheroudakis G., et al. (2019).  Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab.. Transl Oncol. 12(5), 739-748.
Koletsa, T., Kotoula V., Koliou G-A., Manousou K., Chrisafi S., Zagouri F., et al. (2020).  Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?. Cancer Immunol Immunother.
Fountzilas, E., Kotoula V., Pentheroudakis G., Manousou K., Polychronidou G., Vrettou E., et al. (2019).  Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer.. ESMO Open. 4(2), e000474.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.